pharma · Ph+ ALL · Unresectable or Metastatic Melanoma or Advanced Solid Tumors
Ascentage Pharma
Ascentage Pharma Group
Ascentage Pharma clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
USA HQ
2009 Founded
178 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- USA
- Founded
- 2009
- Employees
- 178
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Ascentage Pharma projects
2 ClinicalTrials.gov programs sponsored by Ascentage Pharma.
Ascentage Pharma has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Ascentage Pharma have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.